To explore the value of assessing pancreatic cancers with integrated positron emission tomography (PET)/magnetic resonance imaging (MRI), fluorine-18 fluorodeoxyglucose (FDG) PET and diffusion weighted imaging (DWI) were applied. Integrated PET/MR is a promising and powerful tool for pancreatic tumor detection and assessment. It is relatively advantageous to combine PET and DWI together to discriminate malignant tumors from benign lesions.
This abstract and the presentation materials are available to members only; a login is required.